CSF biomarkers for mild cognitive impairment and early Alzheimer's disease

This publication has 100 references indexed in Scilit:

• Differentiation of Geriatric Major Depression From Alzheimer’s Disease With CSF Tau Protein Phosphorylated at Threonine 231
  American Journal of Psychiatry, 2003
• Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
  Movement Disorders, 2002
• Cerebrospinal Fluid Amyloid β1–42 Levels in the Mild Cognitive Impairment Stage of Alzheimer's Disease
  Experimental Neurology, 2001
• Age-Dependent Change in the Levels of Aβ40 and Aβ42 in Cerebrospinal Fluid from Control Subjects, and a Decrease in the Ratio of Aβ42 to Aβ40 Level in Cerebrospinal Fluid from Alzheimer’s Disease Patients
  European Neurology, 2000
• Tau and apo E in CSF
  NeuroReport, 1999
• Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele
  Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1996
• Tau protein and the neurofibrillary pathology of Alzheimer's disease
  Trends in Neurosciences, 1993
• Microtubule formation and neurite growth in cerebellar macroneurons which develop in vitro: evidence for the involvement of the microtubule-associated proteins, MAP-1a, HMW-MAP2 and Tau
  Developmental Brain Research, 1989
• The prevalence of dementia: A quantitative integration of the literature
  Acta Psychiatrica Scandinavica, 1987
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984